Korean biotech firm takes second shot at Singapore backdoor listing
Add BT as a preferred sourceSingapore
A SOUTH KOREAN steelmaker controls a firm that makes kimchi lactobacillus (lactic acid bacteria) is trying again to secure a listing for the latter biotech firm by a backdoor route.
Stainless steel manufacturer Kossen, a key shareholder of BiogenicsKorea, has signed an implementation agreement with Epicentre Holdings (the former authorised Apple retailer) and Tardis Capital, said Epicentre's judicial managers (JMs) on Wednesday.
TRENDING NOW
On the board but frozen out: The Taib family feud tearing Sarawak construction giant apart
Is it time to scrap COE categories for cars?
Thai and Vietnamese farmers may stop planting rice because of the Iran war. Here’s why
As more Asean states turn to Russia for fuel, will Moscow boost its influence in the region?
